Estudio de fase III, abierto, multicéntrico y aleatorizado de palbociclib como tratamiento adyuvante combinado con hormonoterapia en comparación con hormonoterapia sola en pacientes con recidiva locorregional aislada de cáncer de mama extirpado con receptor hormonal positivo y HER2 negativo
Elisabetta Munzone, MD (European Institute of Oncology, Milan)
Stefan Aebi, MD (Lucerne Cantonal Hospital)
Cookie | Duración | Descripción |
---|---|---|
_hjIncludedInSessionSample_2433519 | 2 minutes | Description is currently not available. |
FormsWebSessionId | 1 month | Description is currently not available. |
m | 1 year 1 month 4 days | No description available. |
MC1 | 1 year | No description available. |
RpsAuthNonce | 1 month | Description is currently not available. |
VISITOR_PRIVACY_METADATA | 5 months 27 days | Description is currently not available. |
Cookie | Duración | Descripción |
---|---|---|
_hjAbsoluteSessionInProgress | 30 minutes | Hotjar sets this cookie to detect a user's first pageview session, which is a True/False flag set by the cookie. |